Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-HLA Antibody”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Not applicableStudy completedNCT04888286
What this trial is testing

DSAs in Patients Undergoing Allo-HSCT From Mismatched Donors

Who this might be right for
Hematologic DiseasesStem Cell Transplant Complications
Gruppo Italiano Trapianto di Midollo Osseo 912
Large-scale testing (Phase 3)Study completedNCT04302805
What this trial is testing

RATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT)

Who this might be right for
Kidney Transplantation
Institute for Clinical and Experimental Medicine 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT04827979
What this trial is testing

Daratumumab and Belatacept for Desensitization

Who this might be right for
Highly Sensitized Prospective Kidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 19
Testing effectiveness (Phase 2)Ended earlyNCT01349595
What this trial is testing

Impact of Proteasome Inhibition on Anti-Donor HLA Antibody Production After Kidney Transplantation

Who this might be right for
Disorder of Transplanted Kidney
Mark Stegall 4
Not applicableStudy completedNCT07474857
What this trial is testing

Anti-HLA Antibodies After Bone Regeneration Surgery

Who this might be right for
Alveolar Bone LossMaxillary Sinus Bone Loss
Medical Innovation Center Wroclaw 20
Testing effectiveness (Phase 2)UnknownNCT01502267
What this trial is testing

Desensitization Protocol for Highly Sensitized Patients on the Waiting List for Kidney Transplant

Who this might be right for
End Stage Renal Disease
Seoul National University Hospital 2
Not applicableUnknownNCT03815864
What this trial is testing

Antibodies and Liver Retransplantation

Who this might be right for
Liver Transplant FailureAntibody-mediated Rejection
London Health Sciences Centre 200
Not applicableUnknownNCT02556879
What this trial is testing

Immunization Anti HLA in the Liver Transplant Recipients (DSATH)

Who this might be right for
Liver TransplantationGraft Failure
Assistance Publique - Hôpitaux de Paris 100
Testing effectiveness (Phase 2)Looking for participantsNCT06362967
What this trial is testing

The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to Allo-HSCT

Who this might be right for
High Titers of Anti-HLA Antibody (MFI ≥5000)
Anhui Provincial Hospital 30
Not applicableStudy completedNCT05399693
What this trial is testing

Platelet Transfusion Refractoriness

Who this might be right for
Platelet Transfusion Refractoriness
Institut de cancérologie Strasbourg Europe 50
Early research (Phase 1)Ended earlyNCT00589316
What this trial is testing

Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+7 more
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT03238443
What this trial is testing

Interest of the Donor-specific Antibodies After Liver Transplantation

Who this might be right for
Liver Transplant
University Hospital, Lille 120
Early research (Phase 1)Not Yet RecruitingNCT04579523
What this trial is testing

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma

Who this might be right for
Multiple MyelomaRecurrent Multiple MyelomaRefractory Multiple Myeloma
Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT03897205
What this trial is testing

An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients

Who this might be right for
Kidney Transplant Rejection
Hansa Biopharma AB 30
Not applicableStudy completedNCT07200583
What this trial is testing

Protein A Immunoadsorption in Highly Sensitized Haplo-HSCT Patients

Who this might be right for
Hematologic MalignanciesHematologic DisordersAllogeneic Hematopoietic Stem Cell Transplantation (HSCT)+1 more
Ting YANG 50
Not applicableStudy completedNCT03438058
What this trial is testing

Complement-activating Anti-human Leucocyte Antigen Donor Specific Antibodies in Solid Organ Transplantation

Who this might be right for
Organ Transplant Recipients
Paris Translational Research Center for Organ Transplantation 7,547
Not applicableUnknownNCT03861962
What this trial is testing

Re-evaluation of Donor-specific Anti-HLA Alloantibodies Immunoassay After Organ Transplantation, From Antigen Level to Epitope Level

Who this might be right for
Organ Transplantation
Assistance Publique - Hôpitaux de Paris 20,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT03380962
What this trial is testing

Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant

Who this might be right for
Kidney Failure, ChronicEnd-Stage Renal DiseaseTransplant Glomerulopathy+4 more
Stanley Jordan, MD 20
Not applicableStudy completedNCT06395220
What this trial is testing

Kinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell Transplantation

Who this might be right for
Haematological Malignancy
Peking University People's Hospital 314
Testing effectiveness (Phase 2)Looking for participantsNCT06380816
What this trial is testing

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

Who this might be right for
Advanced Solid TumoursSquamous Cell Carcinoma of Head and NeckCarcinoma, Non-Small-Cell Lung+8 more
Cancer Research UK 167
Load More Results
26